High Rate of Passenger Lymphocyte Syndrome after ABO Minor Incompatible Lung Transplantation
CONCLUSIONS: Minor ABO incompatible LuTX recipients are at considerable risk of developing clinically significant PLS. Post-transplant monitoring combining red cell serology and hemolysis marker determination appears advisable not to overlook hemolytic episodes which necessitate antigen-negative transfusion therapy.PMID:38078854 | DOI:10.1164/rccm.202306-1107OC
Source: American Journal of Respiratory and Critical Care Medicine - Category: Respiratory Medicine Authors: Mirjam M Kohl Stefan Schwarz Peter Jaksch Gabriella Murak özy Martin Kurz Marlies Sch önbacher Alexander Tolios Florian Frommlet Konrad Hoetzenecker G ünther F Körmöczi Source Type: research
More News: Blood Transusion | Laboratory Medicine | Lung Transplant | Respiratory Medicine | Study | Transfusion Therapy | Transplant Surgery | Transplants